These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 23246055)

  • 1. Orthotopic heart transplant versus left ventricular assist device: a national comparison of cost and survival.
    Mulloy DP; Bhamidipati CM; Stone ML; Ailawadi G; Kron IL; Kern JA
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):566-73; discussion 573-4. PubMed ID: 23246055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Readmission and resource utilization after orthotopic heart transplant versus ventricular assist device in the National Readmissions Database, 2010-2014.
    Mukdad L; Mantha A; Aguayo E; Sanaiha Y; Juo YY; Ziaeian B; Shemin RJ; Benharash P
    Surgery; 2018 Aug; 164(2):274-281. PubMed ID: 29885741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends and Cost of Heart Transplantation and Left Ventricular Assist Devices: Impact of Proposed Federal Cuts.
    Patel N; Kalra R; Doshi R; Bajaj NS; Arora G; Arora P
    JACC Heart Fail; 2018 May; 6(5):424-432. PubMed ID: 29724365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative cost-effectiveness of the HeartWare versus HeartMate II left ventricular assist devices used in the United Kingdom National Health Service bridge-to-transplant program for patients with heart failure.
    Pulikottil-Jacob R; Suri G; Connock M; Kandala NB; Sutcliffe P; Maheswaran H; Banner NR; Clarke A
    J Heart Lung Transplant; 2014 Apr; 33(4):350-8. PubMed ID: 24582838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of sensitization in US heart transplant recipients bridged with a ventricular assist device: update in a modern cohort.
    Arnaoutakis GJ; George TJ; Kilic A; Weiss ES; Russell SD; Conte JV; Shah AS
    J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1236-45, 1245.e1. PubMed ID: 21839482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.
    Kamdar F; John R; Eckman P; Colvin-Adams M; Shumway SJ; Liao K
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):575-81. PubMed ID: 23321132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Better With Time: An Economic Assessment of Long-Term Mechanical Circulatory Support in a Population Surviving at Least 1 Year with a Left Ventricular Assist Device.
    Chung JJ; Stetson R; Gordon J; Chen CW; Gaffey AC; Rame JE; Acker M; Atluri P
    Semin Thorac Cardiovasc Surg; 2020 Winter; 32(4):738-746. PubMed ID: 30308249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac replacement therapies: outcomes and costs for heart transplantation versus circulatory assist.
    Mishra V; Fiane AE; Winsnes BA; Geiran O; Sørensen G; Hagen TP; Gude E
    Scand Cardiovasc J; 2017 Feb; 51(1):1-7. PubMed ID: 27248460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National Trends in Utilization, Mortality, Complications, and Cost of Care After Left Ventricular Assist Device Implantation From 2005 to 2011.
    Shah N; Agarwal V; Patel N; Deshmukh A; Chothani A; Garg J; Badheka A; Martinez M; Islam N; Freudenberger R
    Ann Thorac Surg; 2016 Apr; 101(4):1477-84. PubMed ID: 26588867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.
    Clegg AJ; Scott DA; Loveman E; Colquitt J; Hutchinson J; Royle P; Bryant J
    Health Technol Assess; 2005 Nov; 9(45):1-132, iii-iv. PubMed ID: 16303098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pulmonary vascular resistance before left ventricular assist device implantation on short- and long-term post-transplant survival.
    Tsukashita M; Takayama H; Takeda K; Han J; Colombo PC; Yuzefpolskaya M; Topkara VK; Garan AR; Mancini DM; Kurlansky PA; Naka Y
    J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1352-60, 1361.e1-2. PubMed ID: 26253875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical and cost-effectiveness analysis of the HeartMate 3 left ventricular assist device for transplant-ineligible patients: A United Kingdom perspective.
    Lim HS; Shaw S; Carter AW; Jayawardana S; Mossialos E; Mehra MR
    J Heart Lung Transplant; 2022 Feb; 41(2):174-186. PubMed ID: 34922821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of the implantable HeartMate II left ventricular assist device for patients awaiting heart transplantation.
    Moreno SG; Novielli N; Cooper NJ
    J Heart Lung Transplant; 2012 May; 31(5):450-8. PubMed ID: 22115674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Institutional Cost Comparison Between Heart Transplants and Left Ventricular Assist Device Implantations.
    Chimanji N; Kilic A; Hasan A; Higgins RS; Whitson BA; Kilic A
    Exp Clin Transplant; 2016 Dec; 14(6):656-659. PubMed ID: 27063391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.
    Kormos RL; Teuteberg JJ; Pagani FD; Russell SD; John R; Miller LW; Massey T; Milano CA; Moazami N; Sundareswaran KS; Farrar DJ;
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1316-24. PubMed ID: 20132950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost of 1-year left ventricular assist device destination therapy in chronic heart failure: a comparison with heart transplantation.
    Droogne W; Jacobs S; Van den Bossche K; Verhoeven J; Bostic RR; Vanhaecke J; Van Cleemput J; Rega F; Meyns B
    Acta Clin Belg; 2014 Jun; 69(3):165-70. PubMed ID: 24820923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study.
    Mehra MR; Salerno C; Cleveland JC; Pinney S; Yuzefpolskaya M; Milano CA; Itoh A; Goldstein DJ; Uriel N; Gulati S; Pagani FD; John R; Adamson R; Bogaev R; Thohan V; Chuang J; Sood P; Goates S; Silvestry SC
    Circulation; 2018 Oct; 138(18):1923-1934. PubMed ID: 29807933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of left ventricular assist devices (LVADs) for patients with advanced heart failure: analysis of the British NHS bridge to transplant (BTT) program.
    Clarke A; Pulikottil-Jacob R; Connock M; Suri G; Kandala NB; Maheswaran H; Banner NR; Sutcliffe P
    Int J Cardiol; 2014 Feb; 171(3):338-45. PubMed ID: 24424339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.